Keywords: astrazeneca, crestor, set, mount, strong, challenge, statin

AstraZeneca's Crestor set to mount strong challenge in statin market

Article | 21 March 2001

Print This

The potential impact of AstraZeneca's new superstatin Crestor(rosuvastatin) on the market for statin drugs, and in particular its threat ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in